These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin. Castaneda-Arellano R; Beas-Zarate C; Feria-Velasco AI; Bitar-Alatorre EW; Rivera-Cervantes MC Front Biosci (Landmark Ed); 2014 Jun; 19(8):1445-55. PubMed ID: 24896364 [TBL] [Abstract][Full Text] [Related]
45. Regeneration in the nervous system with erythropoietin. Maiese K Front Biosci (Landmark Ed); 2016 Jan; 21(3):561-96. PubMed ID: 26709793 [TBL] [Abstract][Full Text] [Related]
46. Erythropoietin: when liability becomes asset in neurovascular repair. Grant MB; Boulton ME; Ljubimov AV J Clin Invest; 2008 Feb; 118(2):467-70. PubMed ID: 18219388 [TBL] [Abstract][Full Text] [Related]
48. Oxidative stress in the brain: novel cellular targets that govern survival during neurodegenerative disease. Chong ZZ; Li F; Maiese K Prog Neurobiol; 2005 Feb; 75(3):207-46. PubMed ID: 15882775 [TBL] [Abstract][Full Text] [Related]
50. Regeneration in the nervous system with erythropoietin. Maiese K Front Biosci (Landmark Ed); 2016 Jan; 21(3):561-596. PubMed ID: 26549969 [TBL] [Abstract][Full Text] [Related]
51. Erythropoietin as an angiogenic factor. Ribatti D; Vacca A; Roccaro AM; Crivellato E; Presta M Eur J Clin Invest; 2003 Oct; 33(10):891-6. PubMed ID: 14511361 [TBL] [Abstract][Full Text] [Related]
52. Charting a course for erythropoietin in traumatic brain injury. Maiese K J Transl Sci; 2016 Mar; 2(2):140-144. PubMed ID: 27081573 [TBL] [Abstract][Full Text] [Related]
53. Erythropoietin and diabetes mellitus. Maiese K World J Diabetes; 2015 Oct; 6(14):1259-73. PubMed ID: 26516410 [TBL] [Abstract][Full Text] [Related]
54. The extra-hematopoietic role of erythropoietin in diabetes mellitus. Choi D; Retnakaran R; Woo M Curr Diabetes Rev; 2011 Jul; 7(4):284-90. PubMed ID: 21644916 [TBL] [Abstract][Full Text] [Related]
55. Parsing Physiological Functions of Erythropoietin One Domain at a Time. Steinman L Neurotherapeutics; 2015 Oct; 12(4):848-9. PubMed ID: 26311151 [TBL] [Abstract][Full Text] [Related]
56. Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus. Maiese K Biomed Pharmacother; 2008; 62(4):218-32. PubMed ID: 18342481 [TBL] [Abstract][Full Text] [Related]
57. Common neuroprotective effects of endothelin receptor a blockade and erythropoietin during hypoxia-associated cell injury. Perspectives of combined treatment. Danielyan L; Buniatian GH; Gleiter CH ScientificWorldJournal; 2006 Apr; 6():449-51. PubMed ID: 16604256 [No Abstract] [Full Text] [Related]
58. Vascular biology: New mechanisms and pathways. Dulak J; Alexander MY; Randi AM Vascul Pharmacol; 2016 Nov; 86():1-2. PubMed ID: 27746374 [No Abstract] [Full Text] [Related]
59. Mitigation of Sodium Iodate-Induced Cytotoxicity in Retinal Pigment Epithelial Cells Koh AE; Subbiah SK; Farhana A; Alam MK; Mok PL Front Cell Dev Biol; 2021; 9():652065. PubMed ID: 33937251 [TBL] [Abstract][Full Text] [Related]
60. Potential use of transgenic domestic pigs expressing recombinant human erythropoietin in diabetes translation research. Baek SY; Chung HJ; Kim KW; Cho KH; Choi I; Lee HT Anim Cells Syst (Seoul); 2019 Feb; 23(1):42-49. PubMed ID: 30834158 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]